# Low-Dose Methotrexate for the Prevention of Atherosclerotic Events

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/low-dose-methotrexate-for-the-prevention-of-atherosclerotic-events/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Paul M. Ridker,Brendan M. Everett,Aruna D. Pradhan,Jean MacFadyen,Daniel H. Solomon,Elaine Zaharris,Virak Mam,Ahmed Hasan,Yves Rosenberg,Erin Iturriaga,Milan Gupta,Michelle Tsigoulis,Subodh Verma,Michael Clearfield,Peter Libby,Samuel Z. Goldhaber,Roger L. Seagle,Cyril Ofori,Mohammad G. Saklayen,Samuel Butman,Narendra Singh,Michel Le May,Olivier F. Bertrand,James Johnston,Nina P. Paynter,Robert J. Glynn |
| Citations | 1,308 |
| DOI | 10.1056/nejmoa1809798 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1809798?articleTools=true |
| OpenAlex ID | https://openalex.org/W2899885364 |
| PMID | 30415610 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Mohammad G. Saklayen](https://scholariq.org/researchers/mohammad-g-saklayen/)
- [Subodh Verma](https://scholariq.org/researchers/subodh-verma/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Inflammasome and immune disorders](https://scholariq.org/topics/inflammasome-and-immune-disorders/)

## Paper topics

- [Inflammasome and immune disorders](https://scholariq.org/topics/inflammasome-and-immune-disorders/)
- [Atherosclerosis and Cardiovascular Diseases](https://scholariq.org/topics/atherosclerosis-and-cardiovascular-diseases/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.